Contributor Nature Comms Behind the paper Behind The Paper: Estimating immune cell infiltration in childhood brain tumours. +1 Yura Grabovska and 1 other Sep 14, 2020
Contributor Nature Comms Behind the paper Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion David Peng Sep 10, 2020
The long non-coding RNA CRNDE regulates IL6 signalling in multiple myeloma Contributor Leukemia Behind the paper The long non-coding RNA CRNDE regulates IL6 signalling in multiple myeloma David Garrick Sep 05, 2020
Regulation of DNA methylation by ERRα reveals a role for IRF4 in breast cancer Contributor Oncogene Behind the paper Regulation of DNA methylation by ERRα reveals a role for IRF4 in breast cancer +1 Vincent Giguère and 1 other Sep 02, 2020
AmpliconReconstructor – revealing focally amplified rearrangements in cancer Contributor Nature Comms Behind the paper AmpliconReconstructor – revealing focally amplified rearrangements in cancer Jens Luebeck Sep 01, 2020
Honeybee venom in breast cancer treatment: Behind the Paper Contributor npj Precision Oncol Behind the paper Honeybee venom in breast cancer treatment: Behind the Paper +1 Ciara Duffy and 1 other Sep 01, 2020
Targeting purine synthesis in ASS1 expressing tumors enhances the response to immune checkpoint inhibitors Contributor Nature Cancer Behind the paper Targeting purine synthesis in ASS1 expressing tumors enhances the response to immune checkpoint inhibitors Ayelet Erez Aug 31, 2020
Role of EZH1 in EZH2-deficient hematopoiesis Contributor Leukemia Behind the paper Role of EZH1 in EZH2-deficient hematopoiesis Kazumasa Aoyama Aug 29, 2020
Contributor Nature Comms Behind the paper Identification of actionable targets and potential immunotherapy strategies to treat gallbladder cancers +4 Kushal Suryamohan and 4 others Aug 28, 2020
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth Contributor Oncogene Behind the paper Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth +1 Patricia V. Elizalde, PhD and 1 other Aug 27, 2020
Novel poorly differentiated endometrial cancer mouse model Contributor Oncogene Behind the paper Novel poorly differentiated endometrial cancer mouse model +1 Xiyin Wang and 1 other Aug 27, 2020
RUNX1 Mutations in the Context of Personalized Approach in Blast Phase Chronic Myeloid Leukemia Contributor Leukemia Behind the paper RUNX1 Mutations in the Context of Personalized Approach in Blast Phase Chronic Myeloid Leukemia +2 Shady Adnan-Awad and 2 others Aug 25, 2020
Glycovariant-based cancer diagnostics at the point of care? Contributor Comms Biology Behind the paper Glycovariant-based cancer diagnostics at the point of care? +2 Sherif Bayoumy and 2 others Aug 23, 2020
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (RIALTO) Contributor Blood Cancer Behind the paper Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (RIALTO) +2 Gerhard Zugmaier and 2 others Aug 21, 2020
Contributor Leukemia Behind the paper Ibrutinib plus chemoimmunotherapy demonstrates preliminary efficacy in children with relapsed/refractory mature B-NHL Amos Burke Aug 21, 2020
Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers Contributor Nature Genetics Behind the paper Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers Paul Mischel, M.D. Aug 21, 2020
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation Contributor Oncogene Behind the paper BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation Nadine Reischmann Aug 20, 2020
Metabolic reprogramming by a cytokine receptor confers glioblastoma resistance to therapy Contributor Nature Comms Behind the paper Metabolic reprogramming by a cytokine receptor confers glioblastoma resistance to therapy +1 Arezu Jahani-Asl and 1 other Aug 17, 2020
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice Contributor Nature Comms Behind the paper HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice Rouven Hoefflin Aug 17, 2020
